Yan M Li
Overview
Explore the profile of Yan M Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Huang Z, Towner J, Li Y, Bucklen B
Cureus
. 2022 Jan;
13(12):e20302.
PMID: 35028207
Introduction Interbody spacers are necessary for achieving disc height restoration when surgical intervention is used for the treatment of severe degenerative disc disease. Minimally invasive lateral lumbar interbody fusion (MIS...
2.
Liu X, Tian W, Kolar B, Johnson M, Milano M, Jiang H, et al.
Magn Reson Imaging
. 2019 Oct;
65:129-135.
PMID: 31644925
Purpose: To investigate the correlation between the FA parameters and Ki-67 labeling index, and their diagnostic performance in grading supratentorial non-enhancing gliomas and neuronal-glial tumors (GNGT). Methods: This institutional review...
3.
Piper K, DeAndrea-Lazarus I, Algattas H, Kimmell K, Towner J, Li Y, et al.
World Neurosurg
. 2017 Nov;
110:e627-e635.
PMID: 29162528
Objective: Reoperation and readmission are often avoidable, costly, and difficult to predict. We sought to identify risk factors for readmission and reoperation after spine surgery and to use these factors...
4.
Hanna B, Li Y, Beutler T, Goyal P, Hall W
J Clin Neurosci
. 2015 May;
22(7):1091-7.
PMID: 25957783
We present a 69-year-old woman who presented with chronic headaches and was found to have a pituitary mass on MRI, which was biopsied and said to be lymphocytic hypophysitis. The...
5.
Li Y, Zhou B, Deng J, Pan Y, Hay N, Hung M
Cancer Res
. 2005 Apr;
65(8):3257-63.
PMID: 15833858
HER2 overexpression, a known prognostic factor in many human cancers, can activate phosphatidylinositol-3 kinase (PI-3K)/Akt pathways and plays an important role in mediating cell survival and tumor development. Hypoxia-inducible factors...
6.
Li Y, Pan Y, Wei Y, Cheng X, Zhou B, Tan M, et al.
Cancer Cell
. 2004 Nov;
6(5):459-69.
PMID: 15542430
The receptor tyrosine kinase HER2 enhances tumor metastasis; however, its role in homing to metastatic organs is poorly understood. The chemokine receptor CXCR4 has recently been shown to mediate the...
7.
Zhou B, Deng J, Xia W, Xu J, Li Y, Gunduz M, et al.
Nat Cell Biol
. 2004 Sep;
6(10):931-40.
PMID: 15448698
The phenotypic changes of increased motility and invasiveness of cancer cells are reminiscent of the epithelial-mesenchymal transition (EMT) that occurs during embryonic development. Snail, a zinc-finger transcription factor, triggers this...
8.
Chen J, Liu J, Shen L, Rau K, Kuo H, Li Y, et al.
Cancer Gene Ther
. 2004 Sep;
11(11):740-7.
PMID: 15359286
Survivin is expressed in many cancers but not in normal adult tissues and is transcriptionally regulated. To test the feasibility of using the survivin promoter to induce cancer-specific transgene expression...
9.
Makino K, Day C, Wang S, Li Y, Hung M
Oncogene
. 2004 Mar;
23(21):3883-7.
PMID: 15021910
Constitutively active HER2/neu activates nuclear factor kappa-B (NF-kappaB) in cells and induces their resistance to apoptotic stimuli such as tumor necrosis factor-alpha (TNF-alpha). Here, we show that integrin-linked kinase (ILK),...
10.
Li Y, Wen Y, Zhou B, Kuo H, Ding Q, Hung M
Cancer Res
. 2003 Nov;
63(22):7630-3.
PMID: 14633680
Bik was initially identified as a BH3-domain-only protein that interacts with E1B 19K. Although systemically administered wild-type Bik significantly inhibited tumor growth and metastasis in an orthotopic nude mouse model,...